How can we reach the target of glucose control in type 1 diabetes?
作者信息
Bloomgarden Zachary
机构信息
Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
出版信息
J Diabetes. 2023 Jun;15(6):462-464. doi: 10.1111/1753-0407.13413. Epub 2023 May 22.
Abstract
摘要
相似文献
1
How can we reach the target of glucose control in type 1 diabetes?
J Diabetes. 2023 Jun;15(6):462-464. doi: 10.1111/1753-0407.13413. Epub 2023 May 22.
2
Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany.
Exp Clin Endocrinol Diabetes. 2018 Jul;126(7):411-428. doi: 10.1055/a-0586-5302. Epub 2018 Jul 5.
3
Clinical considerations when adding a sodium-glucose co-transporter-2 inhibitor to insulin therapy in patients with diabetes mellitus.
Hong Kong Med J. 2019 Aug;25(4):312-319. doi: 10.12809/hkmj197802.
4
Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.
Diabetes Technol Ther. 2018 Jun;20(S2):S242-S249. doi: 10.1089/dia.2018.0100.
5
[Intensive blood glucose reduction: yes or no?].
MMW Fortschr Med. 2015 Mar 5;157(4):18-9. doi: 10.1007/s15006-015-2752-8.
6
Navigating the Seas of Glycemic Control: The Role of Continuous Glucose Monitoring in Type 1 Diabetes Mellitus.
Diabetes Metab J. 2023 May;47(3):345-346. doi: 10.4093/dmj.2023.0125. Epub 2023 May 26.
7
Age appropriate: Should seniors keep very tight glucose control? That's up for debate.
Diabetes Forecast. 2013 Aug;66(8):32-3.
8
Continuous Glucose Monitoring in 2017.
Diabetes Technol Ther. 2018 Feb;20(S1):S13-S29. doi: 10.1089/dia.2018.2502.
9
Effect of inhaled insulin on fasting and postprandial plasma glucose.
Ann Intern Med. 2007 Jun 5;146(11):821; author reply 821-2. doi: 10.7326/0003-4819-146-11-200706050-00016.
10
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)].
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):98-105. doi: 10.1007/s00508-023-02182-8. Epub 2023 Apr 20.
本文引用的文献
1
A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.
Diabetes Technol Ther. 2023 May;25(5):329-342. doi: 10.1089/dia.2022.0558. Epub 2023 Apr 12.
2
Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.
Lancet Diabetes Endocrinol. 2023 May;11(5):314-323. doi: 10.1016/S2213-8587(23)00061-X. Epub 2023 Mar 30.
3
Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms.
Diabetes Res Clin Pract. 2023 May;199:110627. doi: 10.1016/j.diabres.2023.110627. Epub 2023 Mar 20.
4
Advanced hybrid closed loop system use in elderly with type 1 diabetes: Effectiveness and safety in a prospective, observational, 1-year follow-up real-world study.
Diabetes Obes Metab. 2023 Jul;25(7):2034-2037. doi: 10.1111/dom.15055. Epub 2023 Apr 11.
5
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
N Engl J Med. 2023 Mar 16;388(11):991-1001. doi: 10.1056/NEJMoa2210834.
6
Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg Diabetes Prospective Follow-up Database Registry.
J Diabetes Sci Technol. 2024 Sep;18(5):1122-1131. doi: 10.1177/19322968231156601. Epub 2023 Feb 25.
7
Long-term and recent trends in survival and life expectancy for people with type 1 diabetes in Finland.
Diabetes Res Clin Pract. 2023 Apr;198:110580. doi: 10.1016/j.diabres.2023.110580. Epub 2023 Feb 18.
8
Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system.
Diabetes Obes Metab. 2023 Jun;25(6):1688-1697. doi: 10.1111/dom.15023. Epub 2023 Mar 13.
9
Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes.
J Diabetes Sci Technol. 2024 Jul;18(4):889-896. doi: 10.1177/19322968231153882. Epub 2023 Feb 14.
10
Hemoglobin A1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: The CACTI Study.
J Clin Endocrinol Metab. 2023 Jun 16;108(7):e444-e449. doi: 10.1210/clinem/dgad019.
Zotero 插件